The WACC of HLS Therapeutics Inc (HLS.TO) is 5.7%.
| Range | Selected | |
| Cost of equity | 5.60% - 7.90% | 6.75% |
| Tax rate | 3.00% - 5.10% | 4.05% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 5.2% - 6.2% | 5.7% |
| Category | Low | High |
| Long-term bond rate | 3.2% | 3.7% |
| Equity market risk premium | 5.1% | 6.1% |
| Adjusted beta | 0.49 | 0.62 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 5.60% | 7.90% |
| Tax rate | 3.00% | 5.10% |
| Debt/Equity ratio | 1.15 | 1.15 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 5.2% | 6.2% |
| Selected WACC | 5.7% | |